Filing Details

Accession Number:
0001209191-21-039621
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-10 18:35:05
Reporting Period:
2021-06-09
Accepted Time:
2021-06-10 18:35:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808158 Repare Therapeutics Inc. RPTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1477123 Mitchell Lloyd Segal C/O Repare Therapeutics Inc.
7210 Frederick-Banting, Suite 100
St-Laurent A8 H4S 2A1
President And Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-09 1,576 $35.00 96,008 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,000 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020.
  2. These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.